State Ledger
Company profile

REVELATION BIOSCIENCES, INC. CIK 1810560

Tickers
REVB (Nasdaq) · REVBW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92122
Fiscal year end
2025 (FY)
Market Data
Close
$0.78
Change
+$0.03
Change %
3.33%
Volume
1,119

REVB · trading date Oct 12, 2026 · previous close $0.75 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.91M
Total assets
$11.58M
Total liabilities
$2.72M
Stockholders' equity
$8.86M
Cash & equivalents
$10.70M
Operating income
-$9.07M
Operating cash flow
-$8.27M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
23.5%
Equity / assets
76.5%
CapEx / revenue
—
Operating cash flow / net income
0.93×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.91M $11.58M $2.72M $8.86M
2024 — -$15.04M $6.62M $1.91M $4.71M
2023 — -$120.3K $12.21M $5.56M $6.65M
2022 — -$10.83M $5.50M $4.45M $1.05M
2021 — -$11.99M $2.04M $2.14M -$99.5K
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-19
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92122
4660 LAJOLLA VILLAGE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies